InChI=1S/C48H91NO8/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(40-56-48-47(55)46(54)45(53)43(39-50)57-48)42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h17-18,35,37,41-43,45-48,50-51,53-55H,3-16,19-34,36,38-40H2,1-2H3,(H,49,52)/b18-17-,37-35+/t41-,42+,43+,45+,46-,47+,48+/m0/s1 |
WBOZIXHPUPAOIA-JZZPSRGZSA-N |
CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via D-glucosyl-N-acylsphingosine )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via D-glucosyl-N-acylsphingosine )
|
|
(15Z)-N-[(2S,3R,4E)-1-(β-D-glucopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]tetracos-15-enamide
|
β-D-glucosyl-N-(nervonoyl)sphingosine
|
ChEBI
|
1-O-β-D-glucopyranosyl-N-(nervonoyl)sphingosine
|
ChEBI
|
β-D-glucosyl-(1↔1ʼ)-N-(15Z-tetracosenoyl)-sphing-4-enine
|
UniProt
|
β-GlcCer (C24:1)
|
ChEBI
|
β-GlcCer (C24:1)
|
ChEBI
|
C24:1 β-D-glucosyl ceramide
|
ChEBI
|
C24:1 β-GlcCer
|
ChEBI
|
C24:1 GlcCer
|
LIPID MAPS
|
C24:1-β-glucosyl ceramide
|
ChEBI
|
D-glucosyl-β-1,1' N-(15Z-tetracosenoyl)-D-erythro-sphingosine
|
ChEBI
|
GlcCer(d18:1/24:1(15Z))
|
LIPID MAPS
|
GlcCer(d18:1/24:1(15Z))
|
LIPID MAPS
|
GlcCer(d18:1/24:1(15Z))
|
ChEBI
|
Glucosyl(β) Ceramide (d18:1/24:1(15Z))
|
ChEBI
|
Glucosylceramide (d18:1/24:1(15Z))
|
HMDB
|
N-(15Z-tetracosenoyl)-1-β-glucosyl-sphing-4-ene
|
ChEBI
|
N-(15Z-tetracosenoyl)-1-β-glucosyl-sphing-4-enine
|
LIPID MAPS
|
N-[(2S,3R,4E)-1-(β-D-glucopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]-(15Z)-tetracos-15-enamide
|
IUPAC
|
N-nervonoyl-β-D-glucosylsphingosine
|
ChEBI
|
N-nervonoyl-β-glucosylsphingosine
|
ChEBI
|
N-nervonoylglucosylsphingosine
|
ChEBI
|
N-nervonyl-β-D-glucosylsphingosine
|
ChEBI
|
N-nervonyl-β-glucosylsphingosine
|
ChEBI
|
N-nervonylglucosylsphingosine
|
ChEBI
|